'Executive Summary Canada Pharmaceuticals And Healthcare Industry SWOT Canada Political SWOT Canada Economic SWOT Pharmaceutical Business Environment Ratings Table: Americas Pharmaceutical Business Environment Rating Limits To Potential Returns Risks To Realisation Of Returns Canada – Market Summary Regulatory Regime Intellectual Property Developments Pricing And Reimbursement Issues Ontario Invests In Drug Industry Industry Developments Product Approvals And Launches Pharmaceutical Re-import Policy Company Activity National Pharmaceuticals Strategy Generics Sector Research And Development Sector Pharmacy Sector Industry Forecast Scenario Overall Market Forecast Table: Canadian Drug Market Indicators, 2005-2012 Key Growth Factors – Industry Table: Canadian Health Expenditure Indicators, 2005-2012 Key Growth Factors – Macroeconomic Table: Canada – Economic Activity OTC Market Forecast Table: Canadian OTC Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) Generics Market Forecast Table: Canadian Generics Market Indicators, 2005-2012 Patented Market Forecast Table: Canadian Patented Market Indicators, 2005-2012 Export/Import Forecasts Table: Sectoral Trade Indicators, 2004-2012 (US$mn) Other Healthcare Data Forecasts Table: Canadian Socio-Demographic Indicators Competitive Landscape Table: Canada’s Leading Generics Firms, 2006 Company Profiles Leading Multinational Manufacturers Pfizer Merck & Co GlaxoSmithKline Sanofi-Aventis Novartis Indigenous Manufacturers Apotex BMI Forecast Modelling How We Generate Our Pharmaceutical Industry Forecasts Pharmaceutical Industry Pharmaceutical Business Environment Ratings Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Weighting Table: Weighting Of Components Sources
